Development and validation of risk models and molecular diagnostics to permit personalized management of cancer.
about
Risk prediction model for epithelial ovarian cancer using molecular markers and clinical characteristics.microRNA Expression in Prospectively Collected Blood as a Potential Biomarker of Breast Cancer Risk in the BCFR.GPRC5A: An Emerging Biomarker in Human CancerPrediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study
P2860
Development and validation of risk models and molecular diagnostics to permit personalized management of cancer.
description
2013 թվականի հոկտեմբերի 2-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
name
Development and validation of ...... onalized management of cancer.
@en
type
label
Development and validation of ...... onalized management of cancer.
@en
prefLabel
Development and validation of ...... onalized management of cancer.
@en
P2093
P2860
P356
P1433
P1476
Development and validation of ...... onalized management of cancer.
@en
P2093
P2860
P356
10.1002/CNCR.28393
P407
P577
2013-10-02T00:00:00Z